As per FMI’s latest analysis, the United States is projected to continue to dominate the North American hydroxyapatite market during the forecast period, owing to the better healthcare infrastructure, the surge in the number of non-invasive cosmetic surgeries, increasing healthcare spending, and strong presence of leading hydroxyapatite manufacturers.

NEWARK, Del, Nov. 22, 2023 (GLOBE NEWSWIRE) — The hydroxyapatite market is forecast to expand at 7.8% CAGR over the estimated period, as per FMI’s analysis. The industry’s size is predicted to reach a market value of US$ 501.8 million in 2023.

The market is projected to observe heightened demand for dental care, orthopedic implants, and plastic surgery. The expansion of the market is credited to the surged demand for medical implants, urbanization, and robust industrialization. Apart from this, factors, like heightened consumer awareness and surged interest in biomaterial for deployment in prosthetic applications, are expected to augment market growth.

Hydroxyapatite is extensively deployed in biomedical applications to form/coat implants or prostheses and as a filling material. In addition, the surging medical expenses consistent throughout developed economies are further fueling market expansion. As per the University of Toronto’s published journal, Canada devotes 11.1% of its GDP to medical expenses in contrast to other high-income countries.

Request a Sample Report and Explore New Growth Opportunities Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-12308

The surging prevalence of osteoporosis, arthritis, and other joints related products is projected to generate demand for orthopedic devices. As per the latest data released by the Global Burden of Disease (GBD), nearly 1.71 billion of the population is inflicted by musculoskeletal conditions. Some of the commonly witnessed musculoskeletal conditions include psoriatic arthritis, osteopenia, osteoarthritis, and other joint conditions.

The market is projected to be filled with lucrative opportunities due to the advent of hydroxyapatite ceramics. For example, Bio-Rad Laboratories, Inc., which is a leading marketer of clinical diagnostic products and life science research, revealed the introduction of two new chromatography media for process protein purification, namely Nuvia HP-Q Resin and CHT Ceramic Hydroxyapatite XT Media in September 2018. The robust popularity of micro-sized hydroxyapatite is projected to further propel market development.

Geographically, North America is projected to dominate the market globally. Upsurge in investments, dense count of top leading companies, and superior healthcare infrastructure are a few factors that are backing the regional growth.

Top Highlights from the FMI’s Analysis of the Hydroxyapatite Market:

• The United States hydroxyapatite industry is projected to acquire a 26.9% market share in 2023.
• By the end of 2023, the German market is expected to contribute 16.8% value share in the global market.
• The Japan hydroxyapatite industry is projected to acquire a 5.5% market share in the global market in 2023.
• The Australian hydroxyapatite industry is expected to support a 2.4% market share in 2023.
• The China market is expected to showcase a CAGR of 8.1% over the forecast period.
• The Indian market is projected to exhibit a 7.2% CAGR in the upcoming years.
• The United Kingdom hydroxyapatite industry is anticipated to expand at a CAGR of 3.8% in the next ten years.
• Based on grade, the medical grade segment is projected to acquire a 57.3% market share in 2023.
• Under the application category, the dental segment is expected to obtain a maximum share of 40.2% in 2023.

Drive Your Business Growth Strategy: Purchase the Report for Key Insights! https://www.futuremarketinsights.com/checkout/12308

Key Developments in the Hydroxyapatite Industry

• In March 2022, CGBio entered an export agreement with Shanghai Sanyou Medical for US$ 0.077 billion worth of “BONGROS,” a bone substitute, for five years.
• FLUIDINOVA initiated a research and development project called “FLUIDINOVA- Innovation in Nanocrystalline Hydroxyapatite Offering Synthetics and Industrial/ Organizational Processes” in April 2021. With this development, the firm aims to provide new products for medical devices, pharmaceuticals, and the 3D printing segment.
• FLUIDINOVA commenced a project with INKplant in January 2021. This project is expected to create an advanced ‘toolbox’ of technologies to facilitate 3D printing and is anticipated to bolster the hydroxyapatite business of the company.

Key Companies Profiled

• FLUIDINOVA
• SofSera Corporation
• Berkeley Advanced Biomaterials
• Taihei Chemical Industrial Co. Ltd.
• SigmaGraft
• CAM Bioceramics
• APS Materials, Inc.
• Zimmer Biomet
• Bioceramics
• Granulab (M) Sdn Bhd
• Merz Biomaterials
• Sangi Co., Ltd.

Request Your Copy of the Full Report Methodology Now! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-12308

Hydroxyapatite Market Segmentation

By Grade:

• Medical Grade
• Cosmetics Grade
• Research Grade

By Application:

• Dental
• Orthopedic
• Biochemical Research
• Surgical
• Bioceramic Coatings
• Food
• Medicine
• Others

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia & Pacific
• Middle East & Africa

Author

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil and gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Have a Look at Related Research Reports of Chemicals & Materials

The hydroxypropyl distarch phosphate market size is projected to be worth US$ 1.9 billion in 2023. The market is likely to reach US$ 3.3 billion by 2033. The market is further expected to surge at a CAGR of 5.8% during the forecast period 2023 to 2033.

The hydroxyproline market is anticipated to exhibit substantial gains, with the market expanding at around 5.6% CAGR from 2023 to 2033.

The bioceramics and hydroxyapatite market is valued at US$ 3 Billion in 2022. The market is likely to record a CAGR of 6.9% through 2028, reaching US$ 4.4 Billion.

The sodium caseinate market is expected to reach US$ 8.0 billion by 2033. The sodium caseinate market revenue will continue to expand at a moderate CAGR of 4.6%. 

The glycol ethers market size is predicted to grow from US$ 7.66 billion in 2023 to US$ 13.34 billion in 2033. 

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Nandini Singh Sawlani  

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube